137 related articles for article (PubMed ID: 37734854)
21. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
22. New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.
Kapturska KM; Pawlak A
Vet Comp Oncol; 2023 Sep; 21(3):357-377. PubMed ID: 37308243
[TBL] [Abstract][Full Text] [Related]
23. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
[TBL] [Abstract][Full Text] [Related]
24. Surgery and doxorubicin in dogs with hemangiosarcoma.
Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
[TBL] [Abstract][Full Text] [Related]
26. Development of perioperative premature ventricular contractions as an indicator of splenic hemangiosarcoma and median survival times.
Panissidi AA; DeSandre-Robinson DM
Vet Surg; 2021 Nov; 50(8):1609-1616. PubMed ID: 34351008
[TBL] [Abstract][Full Text] [Related]
27. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
[TBL] [Abstract][Full Text] [Related]
28. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
[TBL] [Abstract][Full Text] [Related]
29. [Adjuvant treatment of canine splenic hemangiosarcoma with autologous dendritic cell therapy - a prospective, randomized double-blind study].
Reck A; Gedon J; Kessler M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2023 Dec; 51(6):394-402. PubMed ID: 38056478
[TBL] [Abstract][Full Text] [Related]
30. Treatment of canine hemangiosarcoma: 2000 and beyond.
Clifford CA; Mackin AJ; Henry CJ
J Vet Intern Med; 2000; 14(5):479-85. PubMed ID: 11012108
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
32. Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions.
Kim JH; Megquier K; Thomas R; Sarver AL; Song JM; Kim YT; Cheng N; Schulte AJ; Linden MA; Murugan P; Oseth L; Forster CL; Elvers I; Swofford R; Turner-Maier J; Karlsson EK; Breen M; Lindblad-Toh K; Modiano JF
Mol Cancer Res; 2021 May; 19(5):847-861. PubMed ID: 33649193
[TBL] [Abstract][Full Text] [Related]
33. Canine splenic hemangiosarcoma cells express and activate luteinizing hormone receptors in vitro.
Zwida KH; Kutzler MA
Am J Vet Res; 2022 Nov; 83(12):. PubMed ID: 36327166
[TBL] [Abstract][Full Text] [Related]
34. Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.
Masyr AR; Rendahl AK; Winter AL; Borgatti A; Modiano JF
J Am Vet Med Assoc; 2021 Mar; 258(6):630-637. PubMed ID: 33683962
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
[TBL] [Abstract][Full Text] [Related]
36. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
[TBL] [Abstract][Full Text] [Related]
37. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
Bray JP; Orbell G; Cave N; Munday JS
J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011-2014).
Moore AS; Rassnick KM; Frimberger AE
J Am Vet Med Assoc; 2017 Sep; 251(5):559-565. PubMed ID: 28828962
[TBL] [Abstract][Full Text] [Related]
39. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
40. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs.
Srebernik N; Appleby EC
Vet Rec; 1991 Nov; 129(18):408-9. PubMed ID: 1767484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
